HIV SeropositivityHIV SeroprevalenceHIV InfectionsSubstance Abuse, IntravenousRisk FactorsSexual BehaviorSeroepidemiologic StudiesAntibodies, ViralCholecystostomyAntibodies, BacterialChlamydophila pneumoniaeRisk AssessmentChlamydophila InfectionsImmunoglobulin GTreatment OutcomeSerologic TestsPrevalenceProspective StudiesEnzyme-Linked Immunosorbent AssayHIV SeronegativityRetrospective StudiesHelicobacter pyloriHelicobacter InfectionsRiskFollow-Up StudiesToxocariasisCross-Sectional StudiesAge FactorsAntibodies, ProtozoanPrognosisTime FactorsCytomegalovirus InfectionsCohort StudiesLogistic ModelsMultivariate AnalysisPredictive Value of TestsToxoplasmosisAcquired Immunodeficiency SyndromeToxocaraHerpesvirus 2, HumanAIDS SerodiagnosisHIV-1Myocardial InfarctionBlood DonorsOdds RatioHepatitis CPatient SelectionNeosporaIncidenceCase-Control StudiesCoronary DiseasePapillomavirus InfectionsHyperamylasemiaRural PopulationSyphilisHerpes GenitalisCytomegalovirusToxoplasmaImmunoglobulin ABrazilRecurrenceHomosexualityUnited States